EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

The Miao Formula MYYAT Augments the Antitumor Activity of Cisplatin in Small Cell Lung Cancer Models and is Associated with Changes in SHP2–PI3K/mTOR Signaling

Xiao Li iD, Mei Yu, Yi Yang, Jun Zhang, Xian Luo, Kelin Wang, Guoqing Zhu, Liu He, Bo Li, Zhengxing Ge

Cancer Management and Research · 2026-11 · Volume 18 · 1-21

DOI: 10.2147/cmar.s637368 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Management and Research, 2026-11. Verfasst von Xiao Li und 9 weiteren Autor:innen. Beteiligte Einrichtung: Second Clinical Medical College, Guizhou University of Traditional Chinese Medicine, Guiyang, People's Republic of China. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

MYYATMiao-Yao-Yi-Ai-TangPI3K/AKT/mTOR signaling pathwaySHP2/PTPN11cisplatin combination therapynetwork pharmacologysmall cell lung cancer

Autor:innen und Institutionen

  • Second Clinical Medical College, Guizhou University of Traditional Chinese Medicine, Guiyang, People's Republic of China.
  • Intensive Care Unit, Leshan Hospital of Traditional Chinese Medicine, Affiliated to Chengdu University of Chinese Medicine, Leshan, People's Republic of China.
  • Department of Respiratory Medicine, The Second Affiliated Hospital of Guizhou University of Traditional Chinese Medicine, Guiyang, People's Republic of China.

ORCID-Profile: Xiao Li

Zitieren

APA

Li, X., Yu, M., Yang, Y., Zhang, J., Luo, X., Wang, K., Zhu, G., He, L., Li, B., & Ge, Z. (2026). The Miao Formula MYYAT Augments the Antitumor Activity of Cisplatin in Small Cell Lung Cancer Models and is Associated with Changes in SHP2–PI3K/mTOR Signaling. Cancer Management and Research, Volume 18, 1-21. https://doi.org/10.2147/cmar.s637368

Vancouver

Li X, Yu M, Yang Y, Zhang J, Luo X, Wang K, et al. The Miao Formula MYYAT Augments the Antitumor Activity of Cisplatin in Small Cell Lung Cancer Models and is Associated with Changes in SHP2–PI3K/mTOR Signaling. Cancer Management and Research. 2026;Volume 18:1-21. doi:10.2147/cmar.s637368

BibTeX
@article{Li2026,
  author = {Li, Xiao and Yu, Mei and Yang, Yi and Zhang, Jun and Luo, Xian and Wang, Kelin and Zhu, Guoqing and He, Liu and Li, Bo and Ge, Zhengxing},
  title = {The Miao Formula MYYAT Augments the Antitumor Activity of Cisplatin in Small Cell Lung Cancer Models and is Associated with Changes in SHP2–PI3K/mTOR Signaling},
  journal = {Cancer Management and Research},
  year = {2026},
  volume = {Volume 18},
  pages = {1--21},
  doi = {10.2147/cmar.s637368}
}
Kostenlos starten →